460: Measurement of Acute Phase Reactants as a Diagnostic Tool in Shar-Pei Fever

Grant Status: Closed

Grant Amount: $74,057.11
Anne Avery, DVM, PhD; Colorado State University
April 1, 2005 - March 31, 2007


Breed(s): Chinese Shar-Pei
Research Program Area: Kidney & Urological Disease
Donate to Support this Research Program Area


A proportion of Chinese Shar-Pei suffer from recurrent febrile episodes, sometimes termed Shar-Pei Fever. Some of these dogs may go on to develop amyloidosis, which can cause irreversible kidney failure. At present there is no test to identify puppies that might ultimately go on to develop Shar-Pei fever, to identify patients who have an ambiguous diagnosis, or to test for carriers of the gene(s) responsible. The purpose of this study is to: 1) develop a clinically useful biological test that will identify afflicted patients and puppies that will go on to develop disease, and may eventually be used to monitor patients on therapy; 2) characterize some of the mediators of inflammation that cause the clinical signs; 3) characterize immune system disorders that have been described in Shar-Pei to determine if these disorders are related to Shar-Pei Fever. Simultaneous with this study, a search for the gene(s) involved in the disorder is being carried out at the National Institutes of Health, which can be used to identify both carriers and affected animals early in life. We anticipate that our results will help to focus that effort by providing a better characterization of the disease.


None at this time.

Help Future Generations of Dogs

Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.

Learn How to Help

Get Canine Health News:
Please leave this field empty
American Kennel Club Canine Health Foundation, Inc

8051 Arco Corporate Dr.
Suite 300
Raleigh, NC 27617

Tax ID# 13-3813813


© 2021 AKC Canine Health Foundation | Privacy Policy | Site Map

Site by Blackbaud, Inc.